Houde CA, Khan A, Jacobus SJ, et al. Treatment outcomes and prognostic factors with lenalidomide, bortezomib, and dexamethasone (RVd) alone versus Rvd plus autologous stem cell transplantation (ASCT) in African American (AA) patients (Pts) with newly diagnosed multiple myeloma (NDMM) in the Determination phase 3 trial [abstract]. Blood. 2023;142(suppl 1):4762.
来那度胺
硼替佐米
自体干细胞移植
医学
多发性骨髓瘤
地塞米松
移植
内科学
肿瘤科
外科
出处
期刊:Blood [American Society of Hematology] 日期:2024-06-20卷期号:143 (25): 2676-2676